Vistagen Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vistagen Therapeutics Inc
TickerVTGN
CIK #0001411685
CUSIP92840H400
SectorLife Sciences - Pharmaceutical Preparations
Address384 Oyster Point Boulevard, No 8, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001411685] 10-K
[0001411685] 10-Q
[0001411685] 3
[0001411685] 4
[0001411685] 8-K
[0001411685] D
[0001411685] SC 13D
[0001411685] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Nantahala Capital Management LLC Vistagen Therapeutics Inc [2024-02-14] 0.9
Vanguard Group Inc Vistagen Therapeutics Inc [2024-02-13] 6.79
Stempoint Capital LP Vistagen Therapeutics Inc [2024-02-12] 0.0
TCG Crossover GP II LLC Vistagen Therapeutics Inc [2023-10-16] 81947.5
Biotechnology Value Fund L P Vistagen Therapeutics Inc [2023-10-16] 5.2
Citadel Advisors LLC Vistagen Therapeutics Inc [2023-10-16] 5.6
Great Point Partners LLC Vistagen Therapeutics Inc [2023-10-12] 0.99
Point72 Asset Management LP Vistagen Therapeutics Inc [2023-10-05] 5.6
Commodore Capital LP Vistagen Therapeutics Inc [2023-08-09] 19.7
Commodore Capital LP Vistagen Therapeutics Inc [2022-04-14] 5.1
Franklin Resources Inc Vistagen Therapeutics Inc [2022-02-04] 5.1
BlackRock Inc Vistagen Therapeutics Inc [2022-02-04] 6.0
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-03-22] 8.4
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-02-16] 5.4
Venrock Healthcare Capital Partners II LP Vistagen Therapeutics Inc [2021-02-16] 0.99
OrbiMed Advisors LLC Vistagen Therapeutics Inc [2021-02-12] 6.9
Growth Equity Opportunities 17 LLC Vistagen Therapeutics Inc [2021-01-04] 6.8
Rosalind Advisors Inc Vistagen Therapeutics Inc [2020-09-18] 5.4
Lincoln Park Capital Fund LLC Vistagen Therapeutics Inc [2020-01-29] 0.62
Pherin Pharmaceuticals Inc Vistagen Therapeutics Inc [2019-03-08] 8.2
CVI Investments Inc Vistagen Therapeutics Inc [2017-12-20] 6.1
Intracoastal Capital LLC Vistagen Therapeutics Inc [2017-12-20] 0.99
Sabby Management LLC Vistagen Therapeutics Inc [2017-12-14] 0.15
Sphera Funds Management Ltd Vistagen Therapeutics Inc [2016-06-22] 7.63
Empery Asset Management LP Vistagen Therapeutics Inc [2016-05-19] 0.87
Sabby Management LLC Vistagen Therapeutics Inc [2016-05-13] 6.56
Nexthera Capital LP Vistagen Therapeutics Inc [2016-02-29] 5.3
Calm SEAS Capital LLC Vistagen Therapeutics Inc [2016-02-05] 5.87
Form 3/4/5 Filer 2011 - 2025
Anderson Cynthia Lynn
Vistagen Therapeutics, Inc.
Prince Joshua S.
Adler Reid G.
Singh Shawn
Cote Elissa S.
FitzPatrick Margaret M
GIN Jerry B
Curley Joanne
Cunningham Ann Michelle
Rotunno Mary L.
SAXE Jon S
Commodore Capital LP
Dotson Jerrold Duane
Smith Mark Alan
Shah Nimish P
VHCP Co-Investment Holdings II, LLC
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Management II, LLC
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
Venrock Healthcare Capital Partners EG, L.P.
Venrock Healthcare Capital Partners II, L.P.
Snodgrass H Ralph
Underdown Brian J.
Ginski Mark J
McPartland Mark A
Rice A Franklin
Bonfiglio Gregory A.
Cato Allen Easley
Cato Holding Co
Form 13F Holdings
Firm Period DFND Voting Shares
TCG Crossover Management LLC [2025-06-30] SOLE 2,676,580 2,676,580
Stempoint Capital LP [2025-06-30] SOLE 2,137,168 2,413,254
Nantahala Capital Management LLC [2025-06-30] SOLE 1,978,492 1,978,492
Vanguard Group Inc [2025-06-30] SOLE 0 1,748,833
Commodore Capital LP [2025-06-30] SOLE 1,575,000 1,575,000
JPMorgan Chase & Co [2025-06-30] DFND 748,862 748,862
Ikarian Capital LLC [2025-06-30] SOLE 601,703 601,703
Sphera Funds Management Ltd [2025-06-30] DFND 447,939 447,939
Adar1 Capital Management LLC [2025-06-30] SOLE 420,765 420,765
BlackRock, Inc. [2025-06-30] SOLE 416,889 416,889
Diadema Partners LP [2025-06-30] SOLE 404,122 404,122
Geode Capital Management LLC [2025-06-30] DFND 272,907 272,907
Almitas Capital LLC [2025-06-30] SOLE 261,399 261,399
Advisorshares Investments LLC [2025-06-30] SOLE 203,114 203,114
Boothbay Fund Management LLC [2025-06-30] OTR 0 177,858
BML Capital Management LLC [2025-06-30] SOLE 0 150,000
Susquehanna International Group LLP [2025-06-30] OTR 115,368 115,368
Citadel Advisors LLC [2025-06-30] DFND 103,000 103,000
State Street Corp [2025-06-30] DFND 96,858 96,858
Jane Street Group LLC [2025-06-30] DFND 95,051 95,051
Two Sigma Investments LP [2025-06-30] SOLE 89,451 89,451
Persistent Asset Partners Ltd [2025-06-30] SOLE 86,819 86,819
Blair William & Co/IL [2025-06-30] SOLE 85,866 85,866
Northern Trust Corp [2025-06-30] DFND 48,093 48,093
Dimensional Fund Advisors LP [2025-06-30] SOLE 43,362 43,362
Renaissance Technologies LLC [2025-06-30] SOLE 40,500 40,500
Marshall Wace LLP [2025-06-30] OTR 0 34,638
American Century Companies Inc [2025-06-30] DFND 31,063 31,063
Two Sigma Advisers LP [2025-06-30] SOLE 24,991 25,832
Charles Schwab Investment Management Inc [2025-06-30] SOLE 23,302 23,302
Prev | Page 6 | Next
Terms | Privacy | Guide
tony@aum13f.com